Reveal Biosciences Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Reveal Biosciences operates at the intersection of biotechnology research and computational pathology, combining traditional tissue analysis with artificial intelligence to turn tissue biology into actionable data. The company maintains a pipeline that includes a high-plex platform and AI-driven pathology workflows designed to provide more accurate and efficient analysis of tissue samples. This approach supports researchers and clinical laboratories in both research and diagnostic contexts. Its services target pharmaceutical and biotech companies, academic institutions, and government agencies, offering tissue-based technologies and image analysis to support study design, diagnostics, and regulatory workflows. Based in San Diego, California, the company is positioned within the biotechnology research industry as a provider of AI-enabled pathology solutions that enable more precise interpretation of tissue samples. A notable development in its history is that the company was acquired by CellCarta Group in May 2021.